Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting

Replication-defective adenovirus (ADV) and poxvirus vectors have shown potential as vaccines for pathogens such as Ebola or human immunodeficiency virus in nonhuman primates, but prior immunity to the viral vector in humans may limit their clinical efficacy. To overcome this limitation, the effect o...

Celý popis

Podrobná bibliografie

Vydáno v:	J Virol
Hlavní autoři:	Yang, Zhi-yong, Wyatt, Linda S., Kong, Wing-pui, Moodie, Zoe, Moss, Bernard, Nabel, Gary J.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 2003
Témata:	Vaccines and Antiviral Agents
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12477888/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.1.799-803.2003
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!